BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3653769)

  • 1. The evaluation of postoperative irradiation in patients with early-stage ovarian cancer.
    Leers WH; Kock HC
    Gynecol Oncol; 1987 Sep; 28(1):41-9. PubMed ID: 3653769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of postoperative radiation therapy in stage I through III epithelial ovarian carcinoma.
    Fuller DB; Sause WT; Plenk HP; Menlove RL
    J Clin Oncol; 1987 Jun; 5(6):897-905. PubMed ID: 3585445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of postoperative radiotherapy by the moving strip technique for malignant ovarian tumor].
    Fujiwara A; Mitao M; Nagai N; Matsumoto K; Katsube Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Jul; 35(7):873-81. PubMed ID: 6875342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes.
    Firat S; Murray K; Erickson B
    Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):201-7. PubMed ID: 12909234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the prognostic factors in patients with stage-I and -II ovarian cancer treated by an operation + irradiation variant].
    Tarlowska L; Czesnin K; Psikuta M; Romejko M
    Vopr Onkol; 1986; 32(3):36-44. PubMed ID: 3962255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Radiotherapy of malignant ovarian tumors using 42 megavolt photons].
    Halama J; Fiebach O
    Fortschr Geb Rontgenstr Nuklearmed; 1972; ():Suppl:7-8. PubMed ID: 4344611
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical characteristics and prognosis of epithelial ovarian cancer in young women].
    Tang L; Zheng M; Xiong Y; Ding H; Liu FY
    Ai Zheng; 2008 Sep; 27(9):951-5. PubMed ID: 18799034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Radiotherapy in primary radically operated ovarian cancer].
    Frischbier HJ; Bahnsen J
    Onkologie; 1985 Oct; 8(5):310-5. PubMed ID: 2999669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immediate and late results of treating serous cystadeno-carcinoma of the ovaries with radiation therapy].
    Sitnikova GP
    Vopr Onkol; 1974; 20(4):29-34. PubMed ID: 4439811
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of radiotherapy for state I ovarian carcinoma].
    Sheng X; Sun J; Zhou C
    Zhonghua Zhong Liu Za Zhi; 1996 Jul; 18(4):314-6. PubMed ID: 9387332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is adjuvant radiotherapy in early stages (FIGO I-II) of epithelial ovarian cancer a treatment of the past?
    Skirnisdottir I; Nordqvist S; Sorbe B
    Oncol Rep; 2005 Aug; 14(2):521-9. PubMed ID: 16012740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Epithelial cancer of the ovary in adults: prognostic and therapeutic study of 95 cases].
    Fignon A; Chauvet B; Body G; Calais G; Fetissof F; Kone M; Le Floch O; Lansac J
    Ann Chir; 1990; 44(4):283-9. PubMed ID: 2192681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole abdominal and pelvic irradiation in patients with minimal disease at second-look surgical reassessment for ovarian carcinoma.
    Hoskins WJ; Lichter AS; Whittington R; Artman LE; Bibro MC; Park RC
    Gynecol Oncol; 1985 Mar; 20(3):271-80. PubMed ID: 3972290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Ovarian adenocarcinomas: 5 year results of treatment of 157 cases irradiated at Fondation Curie (1956-1968)].
    Mathieu G; Fenton J; Rousseau J
    Bull Cancer; 1974; 61(2):161-76. PubMed ID: 4219286
    [No Abstract]   [Full Text] [Related]  

  • 16. Associations between residual disease and survival in epithelial ovarian cancer by histologic type.
    Melamed A; Manning-Geist B; Bregar AJ; Diver EJ; Goodman A; Del Carmen MG; Schorge JO; Rauh-Hain JA
    Gynecol Oncol; 2017 Nov; 147(2):250-256. PubMed ID: 28822556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of various factors on the results of chemotherapy in patients with recurrent ovarian serous cystadenocarcinoma].
    Dzhilavian GA; Vinokurov VL
    Vopr Onkol; 1984; 30(3):16-21. PubMed ID: 6424327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stage I epithelial ovarian tumors of low malignant potential.
    Sawada M; Yamasaki M; Urabe T; Hashimoto K; Katayama S
    Jpn J Clin Oncol; 1991 Feb; 21(1):30-4. PubMed ID: 2067119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective treatment of stage I uterine papillary serous carcinoma with high dose-rate vaginal apex radiation (192Ir) and chemotherapy.
    Turner BC; Knisely JP; Kacinski BM; Haffty BG; Gumbs AA; Roberts KB; Frank AH; Peschel RE; Rutherford TJ; Edraki B; Kohorn EI; Chambers SK; Schwartz PE; Wilson LD
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(1):77-84. PubMed ID: 9422561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of survival of patients with epithelial ovarian carcinoma following whole abdomen irradiation (WAR).
    Weiser EB; Burke TW; Heller PB; Woodward J; Hoskins WJ; Park RC
    Gynecol Oncol; 1988 Jun; 30(2):201-8. PubMed ID: 3371745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.